Clinical and Therapeutic Evaluation of the Infection by HIV/AIDS

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The aim of the Post Marketing Study (PMS) is to evaluate the efficacy and safety profile of nevirapine in the management of the HIV/AIDS in an open environment.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Boehringer Ingelheim
• Treatments: Nevirapine

Criteria

Inclusion Criteria:

• diagnosis of HIV/AIDS, no age limits

• patients could be naïve to treatment or pretreated with other antiretroviral agents

Exclusion Criteria:

• Patients with known hypersensitivity to nevirapine or any other component of the product